-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C3D0Eh0ISLBRWnKo7s1OfESjM/UKDxatc1Orfzn9/idNUY9aU0GJ/HQwq0kyZdSU oBBtQ6LOVhkG/Y5DYSB8oQ== 0001033409-04-000004.txt : 20041117 0001033409-04-000004.hdr.sgml : 20041117 20041117115824 ACCESSION NUMBER: 0001033409-04-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20041116 FILED AS OF DATE: 20041117 DATE AS OF CHANGE: 20041117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESHELMAN FREDRIC N CENTRAL INDEX KEY: 0001033409 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-27570 FILM NUMBER: 041151358 BUSINESS ADDRESS: BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: PPD INC STREET 2: 3151 17TH STREET EXTENSION CITY: WILMINGTON STATE: NC ZIP: 28412 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PHARMACEUTICAL PRODUCT DEVELOPMENT INC CENTRAL INDEX KEY: 0001003124 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 561640186 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 BUSINESS PHONE: 9102510081 MAIL ADDRESS: STREET 1: 3151 SOUTH 17TH ST CITY: WILMINGTON STATE: NC ZIP: 28412 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-11-16 0001003124 PHARMACEUTICAL PRODUCT DEVELOPMENT INC PPDI 0001033409 ESHELMAN FREDRIC N 6814 TOWLES ROAD WILMINGTON NC 28409 1 1 0 0 Chief Executive Officer Common Stock 4964263 D Stock options (to buy) 42.38 2004-11-16 4 A 0 125000 0 A 2005-11-16 2014-11-15 Common Stock 125000 585000 D The options will vest over a four-year period with 31,250 options vesting on 11/16/05; 31,250 vesting on 11/16/06; 31,250 vesting on 11/16/07 and 31,250 vesting on 11/16/08. Lisa C. Noecker attorney-in-fact for Fredric N. Eshelman 2004-11-17 -----END PRIVACY-ENHANCED MESSAGE-----